NASDAQ:KERX - Keryx Biopharmaceuticals SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
Sign in or create an account to add this stock to your watchlist.
Previous Close$3.36
Today's Range$2.9650 - $3.4650
52-Week Range$2.47 - $5.98
Volume2.60 million shs
Average Volume1.69 million shs
Market Capitalization$344.00 million
P/E RatioN/A
Dividend YieldN/A
Beta2.35

SEC Filings

Keryx Biopharmaceuticals (NASDAQ:KERX) SEC Filings

DateFilerForm TypeView
12/26/2018
6:59 AM
Keryx Biopharmaceuticals (Filer)
Form 15-12G
View Filing
12/23/2018
11:18 PM
Keryx Biopharmaceuticals (Filer)
Form EFFECT
View Filing
12/23/2018
11:18 PM
Keryx Biopharmaceuticals (Filer)
Form EFFECT
View Filing
12/23/2018
11:18 PM
Keryx Biopharmaceuticals (Filer)
Form EFFECT
View Filing
12/23/2018
11:18 PM
Keryx Biopharmaceuticals (Filer)
Form EFFECT
View Filing
12/23/2018
11:18 PM
Keryx Biopharmaceuticals (Filer)
Form EFFECT
View Filing
12/23/2018
11:18 PM
Keryx Biopharmaceuticals (Filer)
Form EFFECT
View Filing
12/23/2018
11:18 PM
Keryx Biopharmaceuticals (Filer)
Form EFFECT
View Filing
12/23/2018
11:18 PM
Keryx Biopharmaceuticals (Filer)
Form EFFECT
View Filing
12/23/2018
11:16 PM
Keryx Biopharmaceuticals (Filer)
Form EFFECT
View Filing
12/23/2018
11:16 PM
Keryx Biopharmaceuticals (Filer)
Form EFFECT
View Filing
12/13/2018
3:40 PM
Keryx Biopharmaceuticals (Issuer)
ROGERS MICHAEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2018
3:39 PM
Enyedy Mark J (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2018
3:37 PM
Holmes Scott A (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2018
3:37 PM
Keryx Biopharmaceuticals (Issuer)
Morrison Jodie Pope (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2018
3:36 PM
Keryx Biopharmaceuticals (Issuer)
Regan Daniel Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2018
3:35 PM
Heffernan Michael Thomas (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2018
3:35 PM
GILMAN STEVEN C (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2018
3:33 PM
Keryx Biopharmaceuticals (Issuer)
Neylan John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2018
3:31 PM
Cameron Kevin J (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2018
3:31 PM
Carberry Christine A. (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2018
3:02 PM
Baupost Group GP, L.L.C. (Reporting)
BAUPOST GROUP LLC/MA (Reporting)
Keryx Biopharmaceuticals (Issuer)
KLARMAN SETH A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2018
2:52 PM
BAUPOST GROUP LLC/MA (Filed by)
Keryx Biopharmaceuticals (Subject)
Form SC 13D/A
View Filing
12/13/2018
8:18 AM
Keryx Biopharmaceuticals (Filer)
Form POS462B
View Filing
12/13/2018
8:15 AM
Keryx Biopharmaceuticals (Filer)
Form POS462B
View Filing
12/13/2018
8:12 AM
Keryx Biopharmaceuticals (Filer)
Form POS462B
View Filing
12/13/2018
8:08 AM
Keryx Biopharmaceuticals (Filer)
Form POSASR
View Filing
12/13/2018
7:23 AM
Keryx Biopharmaceuticals (Filer)
Form POS AM
View Filing
12/13/2018
7:22 AM
Keryx Biopharmaceuticals (Filer)
Form POS AM
View Filing
12/13/2018
7:19 AM
Keryx Biopharmaceuticals (Filer)
Form POS AM
View Filing
12/13/2018
7:15 AM
Keryx Biopharmaceuticals (Filer)
Form POS AM
View Filing
12/13/2018
7:14 AM
Keryx Biopharmaceuticals (Filer)
Form POS AM
View Filing
12/13/2018
7:13 AM
Keryx Biopharmaceuticals (Filer)
Form POS AM
View Filing
12/13/2018
7:09 AM
Keryx Biopharmaceuticals (Filer)
Form POS AM
View Filing
12/13/2018
7:08 AM
Keryx Biopharmaceuticals (Filer)
Form POS AM
View Filing
12/13/2018
7:07 AM
Keryx Biopharmaceuticals (Filer)
Form POS AM
View Filing
12/13/2018
7:05 AM
Keryx Biopharmaceuticals (Filer)
Form POS AM
View Filing
12/13/2018
6:47 AM
Keryx Biopharmaceuticals (Filer)
Form S-8 POS
View Filing
12/13/2018
6:46 AM
Keryx Biopharmaceuticals (Filer)
Form S-8 POS
View Filing
12/13/2018
6:44 AM
Keryx Biopharmaceuticals (Filer)
Form S-8 POS
View Filing
12/13/2018
6:41 AM
Keryx Biopharmaceuticals (Filer)
Form S-8 POS
View Filing
12/13/2018
6:39 AM
Keryx Biopharmaceuticals (Filer)
Form S-8 POS
View Filing
12/13/2018
6:38 AM
Keryx Biopharmaceuticals (Filer)
Form S-8 POS
View Filing
12/13/2018
6:34 AM
Keryx Biopharmaceuticals (Filer)
Form S-8 POS
View Filing
12/13/2018
6:32 AM
Keryx Biopharmaceuticals (Filer)
Form S-8 POS
View Filing
12/13/2018
6:29 AM
Keryx Biopharmaceuticals (Filer)
Form S-8 POS
View Filing
12/13/2018
6:20 AM
Keryx Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/12/2018
3:40 PM
Keryx Biopharmaceuticals (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
View Filing
12/03/2018
3:08 PM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/30/2018
3:37 PM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/30/2018
8:00 AM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/29/2018
3:39 PM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/29/2018
6:03 AM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/28/2018
3:06 PM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/20/2018
3:45 PM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/16/2018
7:49 AM
Keryx Biopharmaceuticals (Issuer)
Neylan John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/16/2018
7:49 AM
Holmes Scott A (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/16/2018
5:10 AM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/16/2018
5:08 AM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/15/2018
4:22 PM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/15/2018
4:18 PM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/13/2018
3:06 PM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/13/2018
3:06 PM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/08/2018
4:32 PM
Keryx Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/08/2018
4:30 PM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
11/08/2018
4:21 PM
Keryx Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/31/2018
3:08 PM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
10/30/2018
4:29 PM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
10/30/2018
4:26 PM
Keryx Biopharmaceuticals (Filer)
Form DEFM14A
View Filing
10/30/2018
3:07 PM
Keryx Biopharmaceuticals (Issuer)
Neylan John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/30/2018
3:07 PM
Holmes Scott A (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/29/2018
4:27 PM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
10/25/2018
4:15 PM
Keryx Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/25/2018
4:13 PM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
10/22/2018
7:50 AM
Carberry Christine A. (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/02/2018
7:00 AM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
09/30/2018
11:00 PM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
09/30/2018
11:00 PM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
09/30/2018
11:00 PM
Keryx Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/14/2018
6:32 AM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
09/14/2018
6:30 AM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
09/06/2018
7:33 AM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
09/06/2018
7:31 AM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
08/16/2018
6:11 AM
Holmes Scott A (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/16/2018
6:10 AM
Keryx Biopharmaceuticals (Issuer)
Neylan John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/09/2018
3:47 PM
Akebia Therapeutics, Inc. (Filed by)
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
08/09/2018
3:15 PM
Keryx Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/08/2018
6:13 AM
Keryx Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/31/2018
3:34 PM
Keryx Biopharmaceuticals (Issuer)
Neylan John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/31/2018
3:34 PM
Holmes Scott A (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/20/2018
4:16 PM
Keryx Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/19/2018
4:09 PM
Carberry Christine A. (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/12/2018
5:02 PM
Cameron Kevin J (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/12/2018
5:01 PM
GILMAN STEVEN C (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/12/2018
5:01 PM
Keryx Biopharmaceuticals (Issuer)
ROGERS MICHAEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/12/2018
5:00 PM
Enyedy Mark J (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/12/2018
5:00 PM
Keryx Biopharmaceuticals (Issuer)
Morrison Jodie Pope (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/12/2018
4:59 PM
Keryx Biopharmaceuticals (Issuer)
Regan Daniel Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/12/2018
4:59 PM
Heffernan Michael Thomas (Reporting)
Keryx Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/11/2018
7:03 AM
Keryx Biopharmaceuticals (Subject)
Form 425
View Filing
This page was last updated on 5/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel